FOR IMMEDIATE RELEASE Release No. 98-26 June 1, 1998

Contact: For the 151st APA Annual Meeting program, new research abstract book, abstracts on disk, or syllabus, call 202-682-6325. To set up an interview with a presenter in Toronto, you may leave a message for that person with the annual meeting message center at 416-585-3620. For specific questions the Annual Meeting press room number is 416-585-3606.

APA ANNUAL MEETING HIGHLIGHTS MONDAY, JUNE 1, 1998

Note: All presentations are embargoed from broadcast, publication, and electronic dispersement until the day of the presentation. Only the presenter with authorization from the chairperson of his/her session can agree to an earlier release. If an embargo is lifted with these provisions, Public Affairs staff will post a notification in the Press Room and on the electronic news and information web sites read by journalists to ensure that no one outlet is granted an exclusive.

8:30 a.m. APA Joint Media Briefing with the National Institute on Drug Abuse (NIDA)

"New Research into Treatments for Drug Abuse"

The briefing will highlight important research that will be presented in the drug addition program track held in during the APA conference. Topics include: drug addiction and the brain; risk and vulnerability to drug abuse; effects of perinatal exposure to drugs, effectiveness of new approaches to treating drug addiction; and special issues including, comorbidity, homelessness, women, youth, families at risk; and HIV/AIDS and drug abuse. Presenter: Alan Leschner, Ph.D., Director, National Institute on Drug Abuse (NIDA)

9:45 a.m. Zeneca Pharmaceuticals Media Briefing

"Schizophrenia: Patient Education Key to Compliance"

New advances in the treatment of schizophrenia combine with patient education in this video produced by the American Psychiatric Association through an unrestricted educational grant from Zeneca is helping physicians educate newly diagnosed patients and their family members with the goal of increasing compliance to treatment. Presenters: Rachel Bloom, Richard Jed Wyatt, M.D.,

Amir Kalali, M.D., Jamie Mullen, M.D.

11:00 a.m. APA Media Briefing - "New Research" featuring presenters on the following topics from the new research program: Internet Addiction presented by Nathan Shapira, M.D. and Toby Goldsmith, M.D. University of Cincinnati (New Research 157), Depression and Menopause presented by Leslie Tam, M.D. University of California, San Diego (New Research 167), Genetic Linkage of Male Homosexuality presented by Alan Sanders, M.D., .National Institutes of Health (New Research 149), and Psychiatric Features of Sex Offenders presented by Susan McElroy, M.D. University of Cincinnati (New Research 424).

1:30 p.m. Janssen Pharmaceutica Media Briefing

"Reporters Can Experience Virtual Schizophrenia"

Janssen's exhibit has interactive virtual hallucination simulations and cognition test demonstration at the Janssen exhibit. At this briefing, researchers will discuss new research into the significance of cognition and positive and negative symptoms in understanding and treating schizophrenia. Presenters: Herbert Meltzer, M.D., Ph.D. ; Phil Harvey, Ph.D.; Gord Singer, patient.

PROGRAM HIGHLIGHTS

New Research Highlights

9:00 a.m. - 10:30 a.m. Patient Satisfaction with ECT (New Research 59) presented by Jesse Goodman, M.D. Mayo Medical School ECT patients have positive attitude about this form of treatment. 1:15 p.m. Relative Risk of Death After Antidepressant Medication Overdose (New Research 102) presented by Donna Chen, M.D., Columbia University This study illustrates an increasing preference for the use of SSRIs over other medications for outpatients with OCD. 2:00 p.m. Quality of Care for Depressed Older Adults in a Large HMO (New Research 105) presented by Jurgen Unutzer, M.D., University of Washington Significant difference between patterns of care in a primary care setting and the recommended guidelines for such care, especially in older people. 3:00 p.m.- 5:00 p.m. Genetic Linkage Study of Male Homosexuality (New Research 149) presented by Alan Sanders, M.D., National Institutes of Health This study attempts to validate a previous linkage found between markers on the X chromosome and homosexual orientation in males. 3:00 p.m.- 5:00 p.m. Psychiatric Evaluation of Individuals with Problematic Use of the Internet (New Research 157) presented by Nathan Shapira, M.D. and Toby Goldsmith, M.D., University of Cincinnati Results of the study provide preliminary evidence that individuals with problematic use of the Internet also have common, treatable psychiatric illnesses. 3:00 p.m.- 5:00 p.m. Prevalence of Depression in Menopause (New Research 167) Presented by Leslie W. Tam, M.D., University of California, San Diego This study documents that there is an association between menopause and depression and suggest that it is an indicator for a recurrence of pre-existing depressive illness.

Session Highlights 9:00 a.m. - 10:30 a.m. Dealing with Violence in Schools. Component Workshop 7 Lois T. Flaherty, M.D., Chairperson, Carl C. Bell, M.D., Paul Fink, M.D., Joan Kinlan, M.D., Joseph Palombi, M.D. The presenters will summarize the current knowledge about risk and protective factors and efficacy of violence prevention and follow up programs. 2:00 p.m. - 5:00 p.m. Risk and Vulnerability to Drug Abuse, sponsored by the National Institute on Drug Abuse, Symposium 9 - topics include behavioral genetic approach to drug abuse liability - Ralph E. Tarter, Ph.D., University of Pittsburgh; familial transmission of drug abuse and comorbid disorders - Kathleen R. Merikangas, Ph.D., Yale University; extent of drug use and dependence in the population - Denise Kandel, Ph.D., Columbia University; and first grade classrooms: course of aggression and prevention - Sheppard G. Kellam, M.D., Johns Hopkins University. 2:00 p.m.- 5:00 p.m. International Health Care and Telepsychiatry, Symposium 11 Ellen N. Rothchild, M.D., Chairperson Peter Yellowlees, M.D., Chairperson Topics include: mental health in Canada: changes and challenges - Pierre A. BeausÈjour, M.D., University of Ottawa; psychiatric care in New Zealand - Janice M. Wilson, M.D., Ministry of Health New Zealand; psychiatric health care in Australia - Harvey A. Whiteford, M.D., Australian Government Health; approaching the millennium: psychiatric care in the United States - Herbert S. Sacks, M.D. 2:00 p.m. - 5:00 p.m. Agitation in the Elderly, Symposium 20 John P. Docherty, M.D., Chairperson Topics include: guidelines and the transmission of knowledge - John P. Docherty, M.D., New York Hospital; methodology of experts consensus guidelines - Daniel Carpenter, Ph.D., New York Hospital; agitation of dementia: treatment principles - George S. Alexopoulos, M.D., Cornell University Medical College; agitation: a neuropsychiatric perspective - Jonathan Silver, M.D., Lenox Hill Hospital; summary of the practice guidelines - David A. Kahn, M.D., Columbia Presbyterian Hospital.